UK markets closed

Tenaya Therapeutics, Inc. (TNYA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.1200-0.0700 (-2.19%)
At close: 04:00PM EDT
3.2100 +0.09 (+2.88%)
After hours: 07:58PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
97,488
98,038
94,537
54,393
31,099
-
Selling general and administrative
33,744
33,155
31,084
18,413
7,813
-
Total operating expenses
131,232
131,193
125,621
72,806
38,912
-
Operating income or loss
-131,232
-131,193
-125,621
-72,806
-38,912
-
Total other income/expenses net
122
53
2
-23
430
-
Income before tax
-124,575
-124,084
-123,665
-72,721
-38,395
-
Income tax expense
0
0
0
0
0
-
Income from continuing operations
-124,575
-124,084
-123,665
-72,721
-38,395
-
Net income
-124,575
-124,084
-123,665
-72,721
-38,395
-
Net income available to common shareholders
-124,575
-124,084
-123,665
-72,721
-38,395
-
Basic EPS
-1.86
-
-2.76
-4.10
-1.41
-0.97
Diluted EPS
-1.86
-
-2.76
-4.10
-1.41
-0.97
Basic average shares
69,026
-
44,824
17,734
27,200
27,074
Diluted average shares
69,026
-
44,824
17,734
27,200
27,074